你即將離開本站

並前往https://cancerres.aacrjournals.org/content/79/4_Supplement/OT2-07-09

Abstract OT2-07-09: A phase Ib study of neratinib, pertuzumab ...

The FDA recently approved neratinib as an adjuvant treatment for HER2+ BC patients who have received trastuzumab for at least 1 year.

確定！ 回上一頁

查詢 「Neratinib」的人也找了：

  1. neratinib中文
    2.
  2. neratinib台灣
    3.
  3. neratinib藥廠
    4.
  4. neratinib健保
    5.
  5. neratinib乳癌
    6.
  6. 乳癌治療指引2020
    7.
  7. neratinib副作用
    8.
  8. nerlynx中文
    9.